A. Elisa and A. Cia, and Developmental Immunology T???? 2: Discrimination of SARD and non-SARD using

P. L. Meroni and P. H. Schur, ANA screening: an old test with new recommendations, Annals of the Rheumatic Diseases, vol.69, issue.8, pp.1420-1422, 2010.
DOI : 10.1136/ard.2009.127100

R. L. Ochs, Y. Muro, Y. Si, H. Ge, E. K. Chan et al., Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions, Journal of Allergy and Clinical Immunology, vol.105, issue.6, pp.1211-1220, 2000.
DOI : 10.1067/mai.2000.107039

V. Ganapathy and C. A. Casiano, Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): What exactly are the autoantibodies trying to tell us?, Arthritis & Rheumatism, vol.278, issue.3, pp.684-688, 2004.
DOI : 10.1002/art.20095

R. L. Ochs, T. W. Stein-jr, C. L. Peebles, R. F. Gittes, and E. M. Tan, Autoantibodies in interstitial cystitis, Journal of Urology, vol.151, issue.3, pp.587-592, 1994.

T. Shinohara, D. P. Singh, and L. T. Chylack-jr, Review: Age-Related Cataract: Immunity and Lens Epithelium-Derived Growth Factor (LEDGF), Journal of Ocular Pharmacology and Therapeutics, vol.16, issue.2, pp.181-191, 2000.
DOI : 10.1089/jop.2000.16.181

T. Daniels, J. Zhang, and I. Gutierrez, Antinuclear autoantibodies in prostate cancer: Immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis, The Prostate, vol.16, issue.1, pp.14-26, 2005.
DOI : 10.1016/S0002-9440(10)65517-4

G. Maertens, P. Cherepanov, and W. Pluymers, LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1

A. Watanabe, M. Kodera, and K. Sugiura, Anti-DFS70 antibodies in 597 healthy hospital workers, Arthritis & Rheumatism, vol.21, issue.3, pp.892-900, 2004.
DOI : 10.7326/0003-4819-121-12-199412150-00009

A. Dellavance, V. S. Viana, E. P. Leon, E. S. Bonfa, L. E. Andrade et al., ?e clinical spectrum of antinuclear antibodies associated with the nuclear dense ?ne speckled immuno?uorescence pattern, ?e Journal of Rheumatology, vol.32, issue.11, pp.2144-2149, 2005.

K. Yamada, S. Senju, and T. Shinohara, Humoral immune response directed against LEDGF in patients with VKH, Immunology Letters, vol.78, issue.3, pp.161-168, 2001.
DOI : 10.1016/S0165-2478(01)00243-7

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=

M. Ayaki, N. Ohoguro, and N. Azuma, Detection of Cytotoxic Anti-LEDGF Autoantibodies in Atopic Dermatitis, Autoimmunity, vol.35, issue.5, pp.319-327, 2002.
DOI : 10.1080/0891693021000003198

H. A. Mariz, E. I. Sato, S. H. Barbosa, S. H. Rodrigues, A. Dellavance et al., Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases, Arthritis & Rheumatism, vol.36, issue.1, pp.191-200, 2011.
DOI : 10.1080/03009740701406577

Y. Muro, K. Sugiura, Y. Morita, and Y. Tomita, High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody?positive patients with autoimmune rheumatic disease, Lupus, vol.26, issue.3, pp.171-176, 2008.
DOI : 10.1016/j.jaut.2005.09.001

M. Mahler, J. G. Hanlyand, and M. J. Fritzler, Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases, Autoimmunity Reviews, vol.11, issue.9, pp.642-645, 2011.
DOI : 10.1016/j.autrev.2011.11.005

E. M. Tan, A. S. Cohen, and J. F. Fries, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis & Rheumatism, vol.31, issue.11, pp.1271-1277, 1982.
DOI : 10.1002/art.1780220817

S. R. Johnson, J. Fransen, and D. Khanna, Validation of potential classification criteria for systemic sclerosis, Arthritis Care & Research, vol.292, issue.Suppl, pp.358-367, 2012.
DOI : 10.1056/NEJM197502202920807

S. Narain, H. B. Richards, and M. Satoh, Diagnostic Accuracy for Lupus and Other Systemic Autoimmune Diseases in the Community Setting, Archives of Internal Medicine, vol.164, issue.22, pp.2435-2441, 2004.
DOI : 10.1001/archinte.164.22.2435

M. R. Arbuckle, M. T. Mcclain, and M. V. Rubertone, Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus, New England Journal of Medicine, vol.349, issue.16, pp.1526-1533, 2003.
DOI : 10.1056/NEJMoa021933

C. Eriksson, H. Kokkonen, M. Johansson, G. Hallmans, G. Wadelland et al., Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden, Arthritis Research & Therapy, vol.13, issue.1, p.30, 2011.
DOI : 10.1136/ard.2004.028225

M. J. Fritzler, The antinuclear antibody test: Last or lasting gasp?, Arthritis & Rheumatism, vol.9, issue.1, pp.19-22, 2011.
DOI : 10.1016/j.autrev.2009.02.033

M. Mahler, M. J. Fritzler, and M. Bl?thner, Identi?cation of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a speci?c target of a subpopulation of anti- Sm antibodies, Arthritis Research & Therapy, vol.7, issue.1, pp.19-29, 2005.
DOI : 10.1186/ar1455

M. Mahler, T. Parker, and C. L. Peebles, Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases, The Journal of Rheumatology, vol.39, issue.11, pp.2104-2110, 2012.
DOI : 10.3899/jrheum.120598

M. Mahler, A. Radice, and R. A. Sinico, Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study, Nephrology Dialysis Transplantation, vol.27, issue.1, pp.243-252, 2011.
DOI : 10.1093/ndt/gfr203

M. Mahler, A. Radice, and W. Yang, Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies, Clinica Chimica Acta, vol.413, issue.7-8, pp.719-726, 2012.
DOI : 10.1016/j.cca.2012.01.004

S. S. Copple, A. D. Sawitzke, A. M. Wilson, A. E. Tebo, and H. R. Hillmadsen, Enzyme-Linked Immunosorbent Assay Screening Then Indirect Immunofluorescence Confirmation of Antinuclear Antibodies, American Journal of Clinical Pathology, vol.135, issue.5, pp.678-684, 2004.

K. Fijorek, D. Fijorek, B. Wisniowska, and S. Polak, BDTcomparator: a program for comparing binary classifiers, Bioinformatics, vol.27, issue.24, pp.3439-3440, 2011.
DOI : 10.1093/bioinformatics/btr574

J. A. Nofuentes and J. D. Castillo, Comparison of the likelihood ratios of two binary diagnostic tests in paired designs, Statistics in Medicine, vol.39, issue.22, pp.4179-4201, 2007.
DOI : 10.1002/9780470317082

K. Watanabe, Y. Muro, K. Sugiura, and Y. Tomita, autoantibodies against DFS70/LEDGF in atopic dermatitis, Autoimmunity, vol.30, issue.6, pp.511-519, 2011.
DOI : 10.1016/j.it.2008.12.004

Y. Ogawa, K. Sugiura, and A. Watanabe, Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain, Journal of Autoimmunity, vol.23, issue.3, pp.221-231, 2004.
DOI : 10.1016/j.jaut.2004.07.003

Y. Shoenfeld and E. Toubi, Protective autoantibodies: Role in homeostasis, clinical importance, and therapeutic potential, Arthritis & Rheumatism, vol.36, issue.9, pp.2599-2606, 2005.
DOI : 10.1161/01.ATV.20.3.703

M. J. Fritzler, Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent, Autoimmunity Highlights, vol.144, issue.Suppl 1, pp.51-58, 2012.
DOI : 10.1016/j.cell.2010.11.054

N. Bizzaro, E. Tonutti, and D. Visentini, Antibodies to the Lens and Cornea in Anti-DFS70-Positive Subjects, Annals of the New York Academy of Sciences, vol.60, issue.1, pp.174-183, 2007.
DOI : 10.1182/blood-2002-02-0513

M. Mahler, J. T. Ngo, J. Schulte-pelkum, T. Luettich, and M. J. Fritzler, Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies, Arthritis Research & Therapy, vol.10, issue.6, p.131, 2008.
DOI : 10.1186/ar2548

M. Mahler, E. D. Silverman, and M. J. Fritzler, Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods, Lupus, vol.166, issue.13, pp.1527-1533, 2010.
DOI : 10.4049/jimmunol.166.7.4780

N. Bizzaro, E. Tonutti, and D. Villalta, Recognizing the dense fine speckled/lens epithelium-derived growth factor/p75 pattern on HEp-2 cells: Not an easy task! Comment on the article by Mariz et al, Arthritis & Rheumatism, vol.63, issue.12, pp.4036-4037, 2011.
DOI : 10.1002/art.30621

W. Y. Craig and T. B. Ledue, The dense fine speckled antinuclear antibody pattern in autoimmune rheumatic disease: Comment on the article by Mariz et al, Arthritis & Rheumatism, vol.63, issue.6, p.1759, 2011.
DOI : 10.1002/art.30347